Cyanotech (OTCMKTS:CYAN) Releases Earnings Results

Cyanotech (OTCMKTS:CYAN) released its quarterly earnings data on Monday. The biotechnology company reported $999.00 earnings per share (EPS) for the quarter, Zacks reports. Cyanotech had a negative return on equity of 21.74% and a negative net margin of 7.14%.

Cyanotech Price Performance

CYAN stock remained flat at $0.52 on Monday. The company had a trading volume of 3 shares, compared to its average volume of 1,013. Cyanotech has a 1-year low of $0.21 and a 1-year high of $0.57. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.01 and a quick ratio of 0.29. The company has a market capitalization of $3.84 million, a P/E ratio of -2.08 and a beta of 0.15. The business has a 50 day simple moving average of $0.43 and a two-hundred day simple moving average of $0.41.

About Cyanotech

Cyanotech Corp. engages in the cultivation, production, and sale of natural products derived from microalgae for the health and human nutrition markets worldwide. Its products include BioAstin Hawaiian Astaxanthin, a dietary antioxidant, which is used as a human dietary supplement and dietary ingredient to support and maintain the body’s natural inflammatory response, enhance skin, and support eye, joint, and immune health; and Hawaiian Spirulina Pacifica, a nutrient-rich dietary supplement that is used for extra energy, a strengthened immune system, cardiovascular benefits, and as a source of antioxidant carotenoids.